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Abstract
The modular Gal4/UAS gene expression system has become an indispensable tool in modern biology. Several large-scale
gene- and enhancer-trap screens in the zebrafish have generated hundreds of transgenic lines expressing Gal4 in unique
patterns. However, the early embryonic expression of the Gal4 severely limits their use for studies on regeneration or
behavior because UAS-driven effectors could disrupt normal organogenesis. To overcome this limitation, we explored the
use of the Gal4 repressor Gal80 in transient assays and with stable transgenes to temporally control Gal4 activity. We also
validated a strategy to delay Gal4-driven gene expression using a morpholino targeted to Gal4. The first approach is limited
to transgenes expressing the native Gal4. The morphant approach can also be applied to transgenic lines expressing the
Gal4-VP16 fusion protein. It promises to become a standard approach to delay Gal4-driven transgene expression and
enhance the genetic toolkit for the zebrafish.
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Introduction
The Gal4 protein from yeast is a transcription factor that
activates the expressionof genes required for growth on galactose.It
does so by binding to an Upstream Activating Sequence (UAS)
located in the promoters of target genes. In the absence of galactose,
Gal4 is inactive due to the activity of the repressor protein Gal80,
which binds to a region of about 30 amino acids in the activation
domain of Gal4, preventing its interaction with the transcriptional
machinery [1,2]. The Gal4/UASsystem has been exploitedto drive
gene expression in animals other than yeast and was initially
employed in Drosophila [3,4]. Nowadays, nearly all research using a
genetic approach in the fly are based on the Gal4/UAS gene-
expression system [5].Several strategies havebeenadoptedtorefine
Gal4 activity in Drosophila. For example, Gal80 has been used to
antagonize Gal4 activity in developing and adult flies [6,7]. Also,
temperature-sensitive mutant forms of Gal80 and Gal4 have been
exploited along with ligand-based technologies to further enhance
conditional control [7]. Although the native Gal4 is highly efficient
in Drosophila, it is a weak activator of transgene expression in the
zebrafish [8]. Thus, its transactivation efficiency has been enhanced
by replacing the C-terminal activation domain of the native Gal4
with the highly acidic activation domain of the herpes simplex virus
VP16 [9,10]. The resulting Gal4-VP16 fusion protein retains the
Gal4’s DNA binding specificity for the UAS but is a vastly more
efficient transcription factor. The improvement of the efficiency of
transgenesis in the zebrafish has created the opportunity to generate
a variety of transgenic lines bearing Gal4 activators or UAS-driven
effectors [11,12,13]. Some of these transgenic lines have already
been useful to analyze early development, but comparatively they
have been less effective as tools to characterize biological processes
during postembryonic or larval stages, including regeneration and
behavior because the early expression of Gal4-driven effector genes
may disrupt the normal development of the target tissues
[13,14,15,16,17]. In the zebrafish, spatiotemporal control of the
Gal4 activity can be achieved by a chemically inducible system
based on the insect-specific ecdysone receptor (EcR) [18]. The
chimaeric transactivator composed of the Gal4 fused to the EcR
(GV-EcR) is able to regulate transcription only after the addition of
the small molecule tebufenozide, thereby allowing a temporal
control of the target gene expression. In addition, clonal expression
of Gal4 can be achieved through the use of the recently developed
MAZe technology. Clones can be induced through heat-shock
promoter-driven CRE recombinase expression, which allows
termporal control of Gal4 activity. However, this technique is not
efficient to express the Gal4 in entire tissues or organs [19]. None of
the hundreds of transgenic Gal4 driver lines currently available use
the inducible form of the Gal4 or can be adapted to MAZe. To
overcome this limitation, here we report two general methods to
temporally control Gal4 activity in the zebrafish. We show that
native Gal4 activity can be repressed using Gal80 in transient assays
by mRNA injection and with a stable transgene expressing the
Gal80 by heat shock. Gal4-VP16, however, could not be repressed
with Gal80 because this fusion protein lacks the binding site for
Gal80. Therefore, we used a morpholino targeted to Gal4-VP16 to
delay its activity until larval stages.
Results and Discussion
Gal80 inhibits Gal4 activity in the zebrafish
To temporally control the activity of the Gal4, we used its
natural repressor Gal80. We first tested whether ectopic Gal80
PLoS ONE | www.plosone.org 1 January 2011 | Volume 6 | Issue 1 | e16587expression would interfere with the normal development of the
zebrafish by injecting synthetic mRNA encoding the full-length
Gal80 into fertilized eggs (Fig. 1). We used doubly-transgenic eggs
derived from a cross between the Tg[hsp70:Gal4] transgenic line
expressing the native form of Gal4 under the control of a heat-
shock promoter and the Tg[UAS:Kaede] that expresses the Kaede
photoconvertible protein upon Gal4 activity. At 10 hours post-
fertilization (hpf), experimental and control embryos were
subjected to a 30-minute heat-shock at 39uC to activate the
expression of the Gal4. The following day, the resulting embryos
were analyzed for gross anatomical defects and for the expression
of green-fluorescent Kaede (Fig. 1A–H). In the non-injected
control fish, we observed that a quarter of the population strongly
expressed Kaede (Fig. 1A–B), which represents the expected ratio
of offspring from heterozygous carrier parents. The embryos that
developed from the Gal80 mRNA injected eggs grew normally,
without any apparent defect and none expressed the fluorescent
protein (Fig. 1E–F). However, at 5 days post-fertilization (dpf), the
larvae derived from the Gal80 RNA injected eggs started to
fluoresce, albeit with lower intensity than the non-injected controls
(Fig. 1C–D, G–H). This result suggests that ubiquitous production
of the Gal80 protein does not cause deleterious effects on zebrafish
development and that it can efficiently inhibit the activity of the
Gal4 in transgenic zebrafish. To ask whether Gal80’s effect
extends to specific cell types, we co-injected the mRNA encoding
Gal80 and a DNA construct encoding the full-length Gal4 under
the control of the HuC neural promoter in eggs from the stable
Tg[UAS:Kaede] transgenic line [20] (Fig. 1I–N). We then assessed
the resulting fish for green fluorescence and compared them with
those injected with the HuC:Gal4 construct alone. At 48 hpf, the
Gal80 expressing animals did not show any fluorescence, whereas
control fish expressed Kaede in scattered neurons (Fig. 1I, L). The
Gal80 RNA-injected embryos begun to express Kaede at 3 dpf,
whose fluorescence peaked at 7 dpf, albeit less intensely than in
control animals (Fig. 1J–K, M–N). These observations demon-
strate that Gal80 is an efficient repressor of Gal4 in neural tissues.
They also suggest that the gradual release of Gal4 inhibition likely
due to the degradation of the Gal80 allows the expression of the
UAS-driven genes at later stages of development with an average
onset at 4 dpf.
Gal4 inhibition by Gal80 is dose-dependent
We tested whether Gal4 repression by Gal80 was dose-
dependent. For this purpose, we generated a stable transgenic
line Tg[UAS:mem-TdTomato] to express the red-fluorescent protein
TdTomato in a Gal4-dependent manner. We co-injected eggs
from this line with a cDNA coding for the full-length Gal4 under
the transcriptional control of the beta-actin promoter for
ubiquitous expression, together with different concentrations of
Gal80 synthetic mRNA (Fig. 2A). At 3 dpf, embryos injected with
50 pg of Gal80 mRNA begun to express TdTomato in scattered
muscle fibers (Fig. 2Ad). Animals from injections with 100 pg of
Gal80 mRNA showed the same onset of TdTomato expression,
but in fewer cells (Fig. 2Ag). Fish from injections with 200 pg of
Gal80 mRNA, however, showed no fluorescence at 3 dpf (Fig. 2Aj).
Starting at 4 dpf, all fish groups were strongly fluorescent but the
200 pg group continued to exhibit lower fluorescence (Fig. 2e–f,
h–iA, k–l). In order to quantify the repressive activity of Gal80, we
looked at the level of Td-Tomato expression at different time
points in cells from fish injected with increasing concentrations of
Gal80 RNA (Fig. 2B). For each condition, we selected individual
cells and imaged them at 3, 4 and 6 dpf (Fig. 2Ba–i). We then
quantified the fluorescence per mm
2 using the ImageJ software
(Fig. 2Bh). Comparisons between conditions confirmed our
observations that the intensity of the red-fluorescence decreases
with increasing amounts of Gal80 RNA. Following the same cells
over time showed that red-fluorescence increased progressively,
suggesting that Gal4-driven transgene expression increases
following Gal80 degradation. The dose-dependent effect of
Gal80 on the production of the fluorescent protein was confirmed
in protein extracts from 3 dpf embryos and western blotting with
an antibody to Td-Tomato (Fig. 3C). Without Gal80 RNA, we
could detect a strong band corresponding to Td-Tomato
(Figure 2Aa). Injections of 50 or 100 ng of Gal80 RNA weakened
the signal, and we could not detect any Td-Tomato protein in
extracts from fish injected with 200 ng of Gal80 RNA. Altogether,
these observations suggest that Gal4 activity can be modulated or
completely blocked by injecting increasing amounts of Gal80
RNA.
Temporal control of Gal80 expression
Our previous approach offers to delay Gal4-driven gene
expression during the first few days of development. However,
we wanted to better control the timing of Gal80 activity. For this
purpose, we created a transgenic line to express a Myc-tagged
Gal80 under the control of a heat-shock promoter (Fig. 3A). The
resulting Tg[hsp70:Gal80-Myc] stable line was then assessed by
crossing it with Tg[UAS:Kaede] transgenics. The doubly-transgenic
eggs were injected with beta-actin:Gal4 DNA. At 24 hpf, embryos
expressing Kaede were subjected to a 30-minute or one-hour heat-
shock at 39uC to activate Gal80 expression. To verify the
expression of the Gal80 protein, we performed an anti-Myc
western blotting (Fig. 3B). Without heat shock, we could not detect
the Gal80 protein. After a 30-minute heat shock, we could detect a
band at the correct size. The signal was stronger after 1-hour heat
shock confirming that Gal80 expression is heat-shock dependent.
We then looked at Gal80 expression in embryos by whole-mount
in situ hybridization 8 hours after heat shock (Fig. 3Ca, d). In
control embryos without heat-shock, we could not detect Gal80
RNA. By contrast, embryos submitted to the heat-shock displayed
widespread expression of Gal80. To test if the Gal80-Myc was
functional, we photo-converted the Tg[hsp70:Gal80-Myc; UAS:-
Kaede] embryos immediately after heat shock to distinguish the
Kaede synthesized before the heat shock (Kaede
red) from the
Kaede synthesized after the heat shock (Kaede
green). At 48 hpf,
the embryos without heat shock were Kaede
red and strongly
Kaede
green (Fig. 3Cb–c). By contrast after heat shock, the embryos
were mainly red, indicating that Kaede expression was blocked by
the heat-shock induced Gal80 (Fig. 3Ce–f). We also fixed 48 hpf
embryos and stained them with an anti-Myc antibody to detect the
Gal80 protein. Although the whole-mount in situ hybridizations
showed ubiquitous expression of Gal80 mRNA, not every cell in
the animal gave a Myc(+) signal, suggesting that expression of the
Gal80-Myc fusion in the transgenic line is mosaic (data not
shown). Cells expressing Gal80-Myc were mainly Kaede
red
(Fig. 3D a–d). Low levels of Kaede
green may be due to incomplete
photoconversion, or to Kaede protein translated from mRNA
present at the time of photoconversion. By contrast, Gal80-Myc(-)
cells were Kaede
red and intensely Kaede
green (Fig. 3De–h).
Together, these results demonstrate that the stable
Tg[hsp70:Gal80-Myc] transgenic line is able to inhibit Gal4 activity
upon heat shock. Possitional effect silencing could explain the lack
of ubiquitous expression in our Tg[hsp70:Gal80-Myc] line. This
problem may be solved by generating additional lines carrying
different insertion sites to select those expressing Gla80 in all cells.
Another possibility to overcome positional effects over the
transgene is to use insulator elements within the plasmid carrying
the hsp70:Gal80-Myc.
Delaying Gal4 Expression in the Zebrafish
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There are currently hundreds of stable transgenic lines
expressing Gal4-VP16 in various cellular populations in nearly
every organ. These lines bear an enormous potential for
regenerative studies. However, the activation of Gal4-VP16
may not be controlled with the natural repressor because Gal80
antagonizes Gal4 by binding its C-terminal activation domain,
which is missing in the Gal4-VP16 fusions [1]. As expected, we
could not repress transgene activation with Gal80 in the two
independent Gal4-VP16 lines that we tested (data not shown).
Thus, we wanted to devise an alternative strategy to control the
timing of Gal4-VP16 activity. For this purpose, we tested the
ability of an antisense morpholino targeted to the first 25 coding
nucleotides of the Gal4 gene to knock-down its translation. First,
we injected 3 ng of a Gal4 morpholino (Gal4MO) into eggs from
a cross between Tg[hsp70:Gal4] and Tg[UAS:mem-TdTomato]
(Fig. 4A). At 24 hpf, the embryos were subjected to a 30-minute
heat-shock at 39uC and looked for red fluorescence during the
following day. The Gal4MO prevented the expression of mem-
TdTomato (Fig. 4Ac–d), whereas the non-injected embryos
displayed strong red fluorescence (Fig. 4Aa–b). Because the
target sequence of the morpholino is shared between the native
Gal4 and the Gal4-VP16 fusion, we tested the same morpholino
in other transgenic lines (Fig. 4B–C). We first used the
Tg[ET(hsp:Gal4VP16
s1006t)] transgenics that express Gal4-VP16
at high levels in lateralis afferent ganglia, the ocular and trunk
muscles and other tissues [13]. Tg[ET(hsp:Gal4VP16
s1006t);UAS:-
Kaede] Gal4-morphants did not express Kaede for at least
72 hours after fertilization (Fig. 4Be). At 4 dpf, green fluorescence
begun to appear (Fig. 4Bf). Kaede expression in these animals
was restricted to ocular muscles, compared to a more widespread
expression in non-injected specimens. This suggests that some
early expression of the Gal4-VP16 is due to non-specific
ubiquitous activation of the heat-shock promoter during embryo-
genesis. We also tested the Gal4MO in the Tg[hspGFF53A]
transgenic line that carries the DNA-binding domain of Gal4
fused to two short transcriptional activation motifs of the VP16
designated Gal4FF [21] (Fig. 4C). The Tg[hspGFF53A] expresses
the Gal4FF in afferent neurons of the ear and the lateral line,
with background expression in axial muscle [22]. The injection of
Gal4MO in eggs from the cross between the Tg[hspGFF53A] and
Tg[UAS:EGFP] blocked green-fluorescence expression during the
first 3 days of development (Fig. 4Cc). At 4 dpf, the fluorescence
started to appear in the injected fish (Fig. 4Cd). The expression
was restricted to the otic and lateralis afferent neurons with very
low muscle expression. To confirm that this repressive effect was
Figure 1. Gal80 expression inhibits Gal4 activity. (A–H) Embryos resulting from a cross between Tg[hsp70:Gal4] and Tg[UAS:Kaede] fish were
either non-injected (NI, A–D) or injected with 100 pg of mRNA encoding full-length Gal80 (E–H). Representative specimens are depicted at 24 hpf (A–
B, N=18 GFP
+/72 fish; E–F, N=0 GFP
+/75 fish) and 5 dpf (C–D, N=18 GFP
+/77 fish; G–H, N=19 GFP
+/82 fish). In H, asterisks indicate the fish
displaying GFP. (I–N) Embryos resulting from a cross of Tg[UAS:Kaede] fish were injected with a DNA encoding full-length Gal4 under the control of
the HuC promoter either alone (NI, I–K, N=32) or with 100 pg of mRNA encoding full-length Gal80 (L–N, N=37). Representative specimens are
depicted at 48 hpf, 3 and 7 dpf.
doi:10.1371/journal.pone.0016587.g001
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PLoS ONE | www.plosone.org 3 January 2011 | Volume 6 | Issue 1 | e16587Figure 2. Gal80 RNA temporarily inhibits Gal4 activity in a dose-dependant manner. (A) Embryos resulting from a cross of Tg[UAS:mem-
TdTomato] fish were injected with a DNA encoding full-length Gal4 under the control of the b-actin promoter alone (a–c) or with 50 pg (d–f, N=21),
100 pg (g–i, N=23) or 200 pg (j–l, N=20) of mRNA encoding full-length Gal80. Representative specimens are depicted at 3, 4 and 6 dpf. (Scale bars:
300 mm). (B) Red fluorescence quantification of tdTomato expressing cells. (a–c) Maximal projection of muscle fibers from a embryo resulting from a
cross of Tg[UAS:mem-TdTomato] fish injected with the b-actin:Gal4 construct alone. The white arrowheads indicate the quantified cell. (d–f) Maximal
projection of muscle fibers from a embryo resulting from a cross of Tg[UAS:mem-TdTomato] fish injected with the b-actin:Gal4 construct and 200 pg
of mRNA encoding full-length Gal80. Z-stacks have been captured at the same settings as in a–c. (g–i) Same as d-f with over-exposure. (Scale bars:
20 mm) (h) Quantitative values of fluorescence per mm
2. Each value corresponds to the average of the mean values obtained for three different
regions of each cell. (C) Anti-tdTomato western blotting of 3dpf fish resulting from a cross of Tg[UAS:mem-TdTomato] fish injected with the b-
actin:Gal4 construct alone or with 50, 100 or 200 pg of mRNA encoding full-length Gal80.
doi:10.1371/journal.pone.0016587.g002
Delaying Gal4 Expression in the Zebrafish
PLoS ONE | www.plosone.org 4 January 2011 | Volume 6 | Issue 1 | e16587Figure 3. Temporal control of Gal80 expression. (A) Schematic representation of the construct hsp70:Gal80-myc. (B) Anti-myc western blotting
of 48 hpf fish resulting from a cross of Tg[hsp70:Gal80-myc] fish after 0, 30 and 60 minutes of heat-shock. (C) Embryos resulting from a cross between
Tg[hsp70:Gal80-Myc] and Tg[UAS:Kaede] fish were not submitted (a–c) or submitted to a one-hour heat-shock (d–f). Representative specimens are
depicted for anti-Gal80 in situ hybridization at 30 hpf (a, d) or for Kaede expression at 2 dpf (b–c, d–e). (Scale bars: 150 mm). (D) Embryos resulting
from a cross between Tg[hsp70:Gal80-Myc] and Tg[UAS:Kaede] fish were injected with a DNA encoding full-length Gal4 under the control of the b-
actin promoter. At 24 hpf, the embryos were subjected to a 30-minute heat-shock at 39 degrees and immediately photo-converted. The following
day, immunostaining anti-myc (c, g) was performed on fish expressing Gal80 (a–d) or not expressing Gal80 (e–h). The figure depicts muscle fibers for
the expression of Kaede
red (a, e) and Kaede
green (b, f). (Scale bars: 20 mm).
doi:10.1371/journal.pone.0016587.g003
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control MO of which the first four base pairs are not
complementary to the Gal4 sequence (Fig. 4D). Although the
fluorescence was less intense than in the non-injected fish, we
could detect strong expression of the EGFP in afferent neurons of
the ear and the lateral line, and in axial muscle at 2 dpf,
confirming the specificity of our Gal4MO.
We next tested whether Gal4 repression by the Gal4MO was
concentration-dependent. For this purpose, we injected increas-
ing amounts of Gal4MO in Tg[hspGFF53A;UAS:EGFP] double
transgenic eggs and followed the green fluorescence over time
(Fig. 5). Embryos injected with 1 ng of Gal4MO expressed
EGFP at 2dpf (Fig. 5F). These animals showed fluorescence in
the otic and posterior lateralis afferent ganglia at 4dpf (Fig. 5G–
H), which increased in brightness by 6dpf (Fig. 5I–J). Injections
of 3ng of Gal4MO produced fluorescent fish at 4 dpf, in which
the EGFP signal was stronger and specific at 6 dpf (Fig. 5K–O).
However, fish from eggs injected with 5 ng of the Gal4MO
s h o w e dl o wE G F Pe v e na t6d p f( F i g .5 P – T ) .T h e s ed a t a
demonstrate that Gal4 and Gal4-VP16 activity can be repressed
in a dose-dependant manner with morpholinos, and that the
eventual release of this repression following morpholino
degradation allows postembryonic expression of Gal4-driven
transgenes.
Delayed activation of Gal4-driven effectors bypasses
tissue assembly
We wanted to further test the Gal4 morphant approach in
animals expressing an effector transgene other than a fluorescent
reporter. The motivation behind it is that UAS:X (where X is an
effector gene that affects cellular fate acquisition or behavior) are
powerful tools for in vivo functional analyses of organ homeostasis
or regeneration. We chose to express a constitutively-active
form of the Notch receptor (N
ICD) because Notch signaling
has been implicated in a multitude of biological processes
[23,24]. First, we crossed a Tg[UAS:N
ICD-Myc] line to the
Tg[ET(hsp:Gal4VP16 s
1001t);UAS:Kaede] double transgenic line that
expresses the Gal4-VP16 in the lateral-line neuromasts, the eyes,
skeletal muscle fibers and several visceral organs [13] (Fig. 6A–F).
Tg[ET(hsp:Gal4VP16s
1001t);UAS:Kaede;UAS:N
ICD-Myc] triple-transgenic
embryos displayed multiple defects due to the unconditional activation
of Notch signaling in many tissues during early development. At
3dpf, for example, they exhibited heart edemas and an inflated yolk
sac (Fig. 6B). Animals carrying the hsp:Gal4VP16s
1001t or the
UAS:N
ICD-Myc transgenes alone showed none of these defects
(Fig. 6A). Interestingly, when triple-transgenic larvae were immersed
in DiASP to label lateral-line hair cells, we observed that they failed
to incorporate the fluorophore in the neuromasts (Fig. 6D–E).
When Tg[ET(hsp:Gal4VP16s
1001t);UAS:Kaede;UAS:N
ICD-Myc] eggs were
Figure 4. Gal4 morpholino temporarily inhibits Gal4 expression in Gal4-VP16 lines. (A) Embryos resulting from a cross between
Tg[hsp70:Gal4] and Tg[UAS:mem-TdTomato] fish were either non-injected (NI, Aa-b, N=27) or injected with 3 ng of Gal4 MO (Ac-d, N=37).
Representative specimens are depicted at 2 dpf. (B) Embryos resulting from a cross of Tg[ET(hsp:Gal4VP16
s1006t);UAS:Kaede] double transgenic animals
were either non-injected (NI, Ba-d, N=47) or injected with 3 ng of Gal4 MO (Be-h, N=52). Representative specimens are depicted at 24 hpf (Ba, e), 4
dpf (Bb, f) and 6 dpf (Bc-d, Bg-h). (C) Embryos resulting from a cross of Tg[hspGFF53A;UAS:EGFP] double transgenic animals were either non-injected
(NI, Ca-b, N=64) or injected with 3 ng of Gal4 MO (Cc-d, N=58). Representative specimens are depicted at 48 hpf (Ca, c) and 4 dpf (Cb, d). (D).
Embryos resulting from a cross of Tg[hspGFF53A;UAS:EGFP] double transgenic animals were either non-injected (NI, Da), injected with 5 ng of Gal4
MO (Db) or injected with 5 ng of a control MO (Dc). Representative specimens are depicted at 48 hpf. (Scale bars: 600 mm for A; 300 mm for B and C,
150 mm for D).
doi:10.1371/journal.pone.0016587.g004
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(Fig. 6C,F), suggesting that the early inhibition of Gal4-VP16
translation with a morpholino is sufficient to bypass the critical
developmental stages in which N
ICD induced these defects. We
extended this approach to additional driver lines. We crossed a
Tg[UAS:N
ICD-Myc] line to the Tg[ET(hsp:Gal4VP16s
1006t)] line
(Fig. 6G–J). As we have shown, this driver line expresses the
Gal4-VP16 in lateralis afferent ganglia, ocular and trunknerves, but
also has strong and variable background expression in muscle and
the heart. At 6 dpf, doubly transgenic embryos showed a strongly
reduced body length, smaller head and eyes, heart oedemas and
inflated yolk sac (Fig. 6G–H). Again, when Tg[ET(hsp:Gal4VP16s
1006t);
UAS:N
ICD-Myc] eggs were injected with the Gal4MO, these defec-
tive phenotypes were absent (Fig. 6I–J). We repeated the experi-
ment crossing the Tg[hspGFF53A;UAS:EGFP] driver with the
Tg[UAS:N
ICD-Myc] e f f e c t o r( F i g .6 K – P ) .T r i p l et r a n s g e n i ca n i m a l s
displayed a very small posterior lateralis afferent ganglion compared to
the Tg[hspGFF53A;UAS:EGFP] double-transgenics that served as
control specimens (Fig. 6K–L). Afferent central projections were also
reduced and there were fewer peripheral axons (Fig. 6N–O).
However, when the triple transgenic eggs were injected with the
Gal4MO, the central projections were normal, the posterior ganglion
bore more cells and the number of peripheral axons increased
( F i g .6 M , P ) .F u r t h e r m o r e ,t h ee x p r e s s i o no ft h eE G F Pa n dt h eN
ICD-
Myc transgenes were more specific. Indeed, we could not detect any
background expression in axial muscle in Gal4MO injected fish
(Fig. 6P). These results demonstrate that the Gal4 morphant approach
is effective in suppressing the detrimental effect on tissue assembly of
the early expression of effector transgenes. Interestingly, we found that
in all stable Gal4-VP16 transgenic lines tested, the ensuing effector
expression in the Gal4 morphants was more specific than that of
control non-injected fish. One explanation for this difference is that
these Gal4-VP16 transgenic lines use a minimal heat-shock promoter,
which can induce non-specific early Gal4 expression. This non-
specific expression may be reduced as animals age. Thus, the
suppression of this initial background expression by the Gal4MO
would result in the visualization of the later, specific expression of
Gal4-VP16.
In conclusion, we have validated two strategies to delay Gal4
activity in the zebrafish. One is based on the Gal80 repressor. The
second takes advantage of a morpholino to temporally knock-
down the translation of Gal4 or Gal4-VP16. Both methods were
effective in delaying Gal4-driven transgene activation. However,
whereas the use of Gal80 is limited to transgenic lines expressing
the native form of Gal4, the morphant approach can be easily
applied to any Gal4-fusion transgenic line. Several large-scale
enhancer-trap screens using various Gal4 constructs have recently
been launched in the zebrafish [13,14,21,25,26,27,28,29]. There-
fore, the implementation of temporal control on these lines will
add to their power. Because most of these lines carry an optimized
version of the Gal4 that prevents the use of Gal80, the Gal4
morphant approach promises to become a standard strategy to
delay transgene activation in studies of behavior, organ homeo-
stasis or regeneration in the zebrafish.
Materials and Methods
Animals
Zebrafish were maintained under standardized conditions and
experiments were conducted in accordance with protocols
approved by the PRBB’s Ethical Committee of Animal Experi-
mentation. The reference from the Ethical Committee for Animals
Research (CEEA) is HLS-08-111-I. Embryos were staged accord-
ing to Kimmel et al. [30]. The Tg[hspGFF53A;UAS:EGFP] has
been described previously [22]. The Tg[ET(hsp:Gal4VP16s
1001t)],
Tg[ET(hsp:Gal4VP16s
1006t)] and Tg[UAS:Kaede] lines was obtained
from Dr.H. Baier [29]. The Tg[UAS:N
ICD-Myc] and Tg[hsp70:Gal4]
have been previously described [24].
Plasmid DNA constructs and injections
The hsp70:Gal80-myc, UAS:mem-TdTomato, b-actin:Gal4
and HuC:Gal4 constructs were obtained using the ‘‘Tol2 kit’’
Figure 5. Gal4 morpholino temporarily inhibits Gal4 expression in a dose-dependant manner. Embryos resulting from a cross of
Tg[hspGFF53A;UAS:EGFP] double transgenic animals were either non-injected (A–E) or injected with 1 ng (F–J), 3 ng (K–O) or 5 ng (P–T) of Gal4 MO
(N=94). Representative specimens are depicted at 2, 4 and 6 dpf. White arrows indicate green fluorescence at the level of the posterior afferent
lateralis ganglion. (Scale bars: 150 mm).
doi:10.1371/journal.pone.0016587.g005
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PLoS ONE | www.plosone.org 7 January 2011 | Volume 6 | Issue 1 | e16587Figure 6. Gal4 morpholino allows bypassing of early developmental stages. (A–F) Embryos resulting from an incross between
Tg[ET(hsp:Gal4VP16
s1001t);UAS:Kaede] double trangenics (A,D) or from Tg[ET(hsp:Gal4VP16
s1001t);UAS:Kaede] with Tg[UAS:N
ICD-Myc] animals (B–C, E–F)
were either non-injected (NI, A–B, D–E) or injected with 3 ng of Gal4 MO (C,F). Representative specimens are depicted at 3 dpf. The lower panel shows
a magnification of the different specimens after DiASP treatment (D–F). (G–J) Embryos resulting from a cross between Tg[ET(hsp:Gal4VP16
s1006t)] and
Tg[UAS:N
ICD-Myc] animals were either non-injected (G and magnification in H) or injected with 3 ng of Gal4 MO (I and magnification in J).
Representative specimens are depicted at 6 dpf. (K–P) Embryos resulting from a cross between Tg[hspGFF53A;UAS:EGFP] double transgenic animals
and either wt (K, N) or Tg[UAS:N
ICD-Myc] (L–M, O–P) animals were either non-injected (K–L, N–O) or injected with 3 ng of Gal4 MO (M, P).
Representative specimens are depicted at 7 dpf. (K–M) Maximal projections of posterior lateralis afferent ganglion (dashed circles) and central
projection (white arrowheads). (N–P) Maximal projections of posterior lateralis afferent nerve. (Scale bars: 150 mm for A–F, H and J; 300 mm for G and I;
100 mm for K–P).
doi:10.1371/journal.pone.0016587.g006
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PLoS ONE | www.plosone.org 8 January 2011 | Volume 6 | Issue 1 | e16587[31]. Entry vectors were generated as described in the Invitrogen
Multisite Gateway manual. PCR were performed using primers to
add att sites onto the end of DNA fragments, using Platinum Pfx
(Invitrogen).
For the generation of the middle entry clone containing the
Gal80 cDNA (using pDONR 221), the forward PCR primer
containing an attB1 site and the reverse primer containing a
reverse attB2 site were used:
For: 59-GGGGACAAGTTTGTACAAAAAAGCAGGCTC-
CACCATGGACTACAACAAGAGATC-39
Rev: 59-GGGGACCACTTTGTACAAGAAAGCTGGGTG-
TAAACTATAATGCGAGATAT-39
For the generation of the middle entry clone containing the Gal4
cDNA (using pDONR 221), the forward PCR primer containing an
attB1 site and the reverse primer containing a reverse attB2 site were
used:
For: 59- GGGGACAAGTTTGTACAAAAAAGCAGGCTC-
CACCATGAAGCTACTGTCTTCTAT-39
Rev: 59-GGGGACCACTTTGTACAAGAAAGCTGGGTGT
TACTCTTTTTTTGGGTTTGGTG-39
PCR products were purified using the Qiaquick gel extraction
kit (Qiagen). BP and LR reaction were performed as described
[31].
The pEntry vectors containing the hsp70 promoter, the myc
tag, the UAS promoter and the b-actin promoter are from the
‘‘Tol2 kit’’ [31]. The pEntry vectors containing the TdTomato,
the membrane targeting sequence and the HuC promoter have
been described previously [32].
20 pg of the Tol2-expression clones and 20 pg of the
transposase synthetic RNA were simultaneously injected into
one-cell stage embryos.
To generate stable transgenic lines, injected embryos were
raised to adulthood. For the Tg[UAS:mem-TdTomato] line, carriers
were identified by crossing adult injected fish with Tg[hsp70:Gal4].
Resulting embryos were submitted to a 30-minute heat shock and
screened for Td-Tomato expression. Alternatively, the offspring
was screened by genotyping using the following primers:
For: 59-ACATGGCCGTCATCAAAGA-39; Rev: 59-CTTGT
ACAGCTCGTCCATGC-39.
For the Tg[hsp70:Gal80-myc], carriers were identified by
genotyping their offspring using the following primers:
For: 59-GTGGCCAGCCATTATGAAGT-39; Rev: 59-GGTA
GGTTTGCCACCTTTGA-39
Morpholinos
Morpholino oligonucleotides were obtained from Gene Tools
(Philomath). The sequence of the morpholino to Gal4 is 59-
GTTCGATAGAAGACAGTAGCTTCAT-39. The sequence of
the control morpholino is 59-ATAGAAGACAGTAGCTTCAT
GGTCC-39. 1 to 5 ng of morpholino were injected into one-cell
stage embryos.
RNA synthesis and injections
59 capped sense RNAs were synthesized using a construct
encoding the transposase or the Gal80 cDNA [33] and the
mMessage mMachine kit (Ambion). 20 pg and 50 to 200 pg of
transposase RNA and Gal80 RNA respectively were injected in
one to 2 cells-stage embryos.
Labeling
For vital labeling of hair cells, zebrafish larvæ were immersed in
a 500 mM solution of DiASP for three minutes at room
temperature in the dark. Treated larvæ were washed briefly to
remove excess fluorophore, anæsthetized in 3-aminobenzoic acid
ethyl ester solution (Sigma), mounted on a glass slide, and aligned
using a hair loop. For immunohistochemistry, larvae were fixed
overnight at 4uC in a solution of 4% paraformaldehyde in
phosphate-buffered saline (PBS) solution containing 1% Tween20.
After fixation, samples were washed in the same solution without
fixative and blocked at room temperature with 10% bovine serum
albumin. Primary- and secondary-antibody incubations were
conducted overnight at 4uC in PBS with 0.2% Tween 20. The
primary mouse monoclonal anti-myc antibody was used at 1/50
(9E10.3, NeoMarkers). Alexa-Fluor 647 goat anti-mouse second-
ary antibody (Invitrogen) was used at 1/1000.
Western blot
Embryos were anæsthetized in 3-aminobenzoic acid ethyl ester
solution (Sigma), protein extracts from the whole embryos were
prepared in 2X Laemmli sample buffer and loaded on SDS/
PAGE. The primary rabbit polyclonal anti-RFP (Rockland)
antibody was used at 1/1000. The primary mouse monoclonal
anti-myc antibody was used at 1/1000 (9E10.3, NeoMarkers).
Alexa-Fluor 680 goat anti-rabbit and anti-mouse secondary
antibodies (Invitrogen) were used at 1/20000.
Imaging
Kaede was photoconverted from green to red fluorescence by
exposing the larvae to 405 nm light for 2 minutes. For low-
resolution images, fish were mounted in 3% Methyl-cellulose and
observed with a stereomicroscope (Leica MZ10F) and images were
taken with a CCD camera (Leica DFC 490). For high-resolution
imaging, fixed samples were mounted in Vectashield mounting
medium (Vector Laboratories). Images were acquired with a Leica
TCS SPE confocal microscope with a 40X oil immersion objective
and Z-stacks were acquired at 0.8 or 0.5 mm intervals. Green (500–
540 nm emission) and red (570–600 nm emission) fluorescence
signals were captured by 488 and 532 nm laser lines. 3D
reconstructions and cropping of Z-stacks were realized with Imaris
software (Bitplane), pictures exported and processed in Adobe
Photoshop and Illustrator softwares. The brightness and contrast of
some pictures have been modified in order to help the reader eye
but always in the same extend when it was calling for comparison.
Fluorescence quantification
To quantify and compare the level of fluorescence, cells
expressing TdTomato were imaged with the same parameters,
avoiding saturation. Quantifications were performed using the
Measure plug-in of the ImageJ software.
Whole-mount in situ hybridization
We generated labelled RNA probes by in vitro transcription
using the DIG/Fluor RNA labeling Mix (Roche). Embryos were
fixed in 4% paraformaldehyde in PBS overnight at 4uC and
whole-mount in situ hybridizations were carried as described by
Thisse et al. [34]. The following antisense probe was used to
characterize gal80 expression: Saccharomyces cerevisiae S288c
chromosome XIII (GenBank accession no. NC_001145), nucleo-
tides 645–1308.
Acknowledgments
We thank Josh Bonkowsky and Chi-Bin Chien for communicationg their
results prior to publication.
Author Contributions
Conceived and designed the experiments: HL-S. Performed the experi-
ments: AF. Analyzed the data: HL-S AF. Contributed reagents/materials/
analysis tools: HL-S AF. Wrote the paper: HL-S AF.
Delaying Gal4 Expression in the Zebrafish
PLoS ONE | www.plosone.org 9 January 2011 | Volume 6 | Issue 1 | e16587References
1. Ma J, Ptashne M (1987) The carboxy-terminal 30 amino acids of GAL4 are
recognized by GAL80. Cell 50: 137–142.
2. Traven A, Jelicic B, Sopta M (2006) Yeast Gal4: a transcriptional paradigm
revisited. EMBO Rep 7: 496–499.
3. Brand AH, Perrimon N (1993) Targeted gene expression as a means of altering
cell fates and generating dominant phenotypes. Development 118: 401–415.
4. Fischer JA, Giniger E, Maniatis T, Ptashne M (1988) GAL4 activates
transcription in Drosophila. Nature 332: 853–856.
5. Duffy JB (2002) GAL4 system in Drosophila: a fly geneticist’s Swiss army knife.
Genesis 34: 1–15.
6. Suster ML, Seugnet L, Bate M, Sokolowski MB (2004) Refining GAL4-driven
transgene expression in Drosophila with a GAL80 enhancer-trap. Genesis 39:
240–245.
7. Zeidler MP, Tan C, Bellaiche Y, Cherry S, Hader S, et al. (2004) Temperature-
sensitive control of protein activity by conditionally splicing inteins. Nat
Biotechnol 22: 871–876.
8. Koster RW, Fraser SE (2001) Tracing transgene expression in living zebrafish
embryos. Dev Biol 233: 329–346.
9. Croston GE, Laybourn PJ, Paranjape SM, Kadonaga JT (1992) Mechanism of
transcriptional antirepression by GAL4-VP16. Genes Dev 6: 2270–2281.
10. Sadowski I, Ma J, Triezenberg S, Ptashne M (1988) GAL4-VP16 is an unusually
potent transcriptional activator. Nature 335: 563–564.
11. Halpern ME, Rhee J, Goll MG, Akitake CM, Parsons M, et al. (2008) Gal4/
UAS transgenic tools and their application to zebrafish. Zebrafish 5: 97–110.
12. Scheer N, Campos-Ortega JA (1999) Use of the Gal4-UAS technique for
targeted gene expression in the zebrafish. Mech Dev 80: 153–158.
13. Scott EK, Baier H (2009) The cellular architecture of the larval zebrafish tectum,
as revealed by gal4 enhancer trap lines. Front Neural Circuits 3: 13.
14. Asakawa K, Kawakami K (2008) Targeted gene expression by the Gal4-UAS
system in zebrafish. Dev Growth Differ 50: 391–399.
15. Kawakami K (2004) Transgenesis and gene trap methods in zebrafish by using
the Tol2 transposable element. Methods Cell Biol 77: 201–222.
16. Kawakami K, Takeda H, Kawakami N, Kobayashi M, Matsuda N, et al. (2004)
A transposon-mediated gene trap approach identifies developmentally regulated
genes in zebrafish. Dev Cell 7: 133–144.
17. Koide T, Miyasaka N, Morimoto K, Asakawa K, Urasaki A, et al. (2009)
Olfactory neural circuitry for attraction to amino acids revealed by transposon-
mediated gene trap approach in zebrafish. Proc Natl Acad Sci U S A 106:
9884–9889.
18. Esengil H, Chang V, Mich JK, Chen JK (2007) Small-molecule regulation of
zebrafish gene expression. Nat Chem Biol 3: 154–155.
19. Collins RT, Linker C, Lewis J (2010) MAZe: a tool for mosaic analysis of gene
function in zebrafish. Nat Methods 7: 219–223.
20. Park HC, Kim CH, Bae YK, Yeo SY, Kim SH, et al. (2000) Analysis of
upstream elements in the HuC promoter leads to the establishment of transgenic
zebrafish with fluorescent neurons. Dev Biol 227: 279–293.
21. Asakawa K, Suster ML, Mizusawa K, Nagayoshi S, Kotani T, et al. (2008)
Genetic dissection of neural circuits by Tol2 transposon-mediated Gal4 gene and
enhancer trapping in zebrafish. Proc Natl Acad Sci U S A 105: 1255–1260.
22. Pujol-Marti J, Baudoin JP, Faucherre A, Kawakami K, Lopez-Schier H (2010)
Progressive neurogenesis defines lateralis somatotopy. Dev Dyn 239: 1919–1930.
23. Artavanis-Tsakonas S, Rand MD, Lake RJ (1999) Notch signaling: cell fate
control and signal integration in development. Science 284: 770–776.
24. Scheer N, Groth A, Hans S, Campos-Ortega JA (2001) An instructive function
for Notch in promoting gliogenesis in the zebrafish retina. Development 128:
1099–1107.
25. Davison JM, Akitake CM, Goll MG, Rhee JM, Gosse N, et al. (2007)
Transactivation from Gal4-VP16 transgenic insertions for tissue-specific cell
labeling and ablation in zebrafish. Dev Biol 304: 811–824.
26. Distel M, Wullimann MF, Koster RW (2009) Optimized Gal4 genetics for
permanent gene expression mapping in zebrafish. Proc Natl Acad Sci U S A
106: 13365–13370.
27. Goll MG, Anderson R, Stainier DY, Spradling AC, Halpern ME (2009)
Transcriptional silencing and reactivation in transgenic zebrafish. Genetics 182:
747–755.
28. Ogura E, Okuda Y, Kondoh H, Kamachi Y (2009) Adaptation of GAL4
activators for GAL4 enhancer trapping in zebrafish. Dev Dyn 238: 641–655.
29. Scott EK, Mason L, Arrenberg AB, Ziv L, Gosse NJ, et al. (2007) Targeting
neural circuitry in zebrafish using GAL4 enhancer trapping. Nat Methods 4:
323–326.
30. Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling TF (1995) Stages
of embryonic development of the zebrafish. Dev Dyn 203: 253–310.
31. Kwan KM, Fujimoto E, Grabher C, Mangum BD, Hardy ME, et al. (2007) The
Tol2kit: a multisite gateway-based construction kit for Tol2 transposon
transgenesis constructs. Dev Dyn 236: 3088–3099.
32. Faucherre A, Pujol-Marti J, Kawakami K, Lopez-Schier H (2009) Afferent
neurons of the zebrafish lateral line are strict selectors of hair-cell orientation.
PLoS One 4: e4477.
33. Lee T, Luo L (1999) Mosaic analysis with a repressible cell marker for studies of
gene function in neuronal morphogenesis. Neuron 22: 451–461.
34. Westerfield M (2007) The Zebrafish Book.
Delaying Gal4 Expression in the Zebrafish
PLoS ONE | www.plosone.org 10 January 2011 | Volume 6 | Issue 1 | e16587